SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001010192-13-000065
Filing Date
2013-06-27
Accepted
2013-06-27 13:45:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 TRANSCEPT SCHEDULE 13G/A 6-27-13 sch13ga.htm SC 13G/A 104271
  Complete submission text file 0001010192-13-000065.txt   105903
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81821 | Film No.: 13936870
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 WISCONSIN CIR SUITE 660 CHEVY CHASE MD 20815
Business Address 2 WISCONSIN CIR SUITE 660 CHEVY CHASE MD 20815 301-656-8500
Roumell Asset Management, LLC (Filed by) CIK: 0001331693 (see all company filings)

IRS No.: 522145132 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13G/A